Biochemical Engineering Special Interest Group
biological engineering professionals
16 March 2016

Vectura lands USD621M merger deal with SkyePharma

Vectura has secured a friendly merger with SkyePharma that will see its chief executive depart as the combined company looks to a new and expanded future. The deal, worth £441.3 million ($621 million), puts together two similar companies that are both based in the U.K. and develop treatments for asthma and other respiratory conditions. Source: Fierce Biotech 16/3/2016

My IChemE

IChemE is a registered charity in England & Wales (214379), and a charity registered in Scotland (SC 039661).